HALO
Price
$59.05
Change
+$1.32 (+2.29%)
Updated
Jul 29 closing price
Capitalization
7.28B
6 days until earnings call
IMCR
Price
$33.91
Change
-$0.03 (-0.09%)
Updated
Jul 29 closing price
Capitalization
1.7B
7 days until earnings call
Interact to see
Advertisement

HALO vs IMCR

Header iconHALO vs IMCR Comparison
Open Charts HALO vs IMCRBanner chart's image
Halozyme Therapeutics
Price$59.05
Change+$1.32 (+2.29%)
Volume$1.47M
Capitalization7.28B
Immunocore Holdings
Price$33.91
Change-$0.03 (-0.09%)
Volume$441.87K
Capitalization1.7B
HALO vs IMCR Comparison Chart in %
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HALO vs. IMCR commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Buy and IMCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (HALO: $59.05 vs. IMCR: $33.85)
Brand notoriety: HALO and IMCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 71% vs. IMCR: 113%
Market capitalization -- HALO: $7.28B vs. IMCR: $1.7B
HALO [@Biotechnology] is valued at $7.28B. IMCR’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whileIMCR’s FA Score has 0 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • IMCR’s FA Score: 0 green, 5 red.
According to our system of comparison, HALO is a better buy in the long-term than IMCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 5 TA indicator(s) are bullish while IMCR’s TA Score has 3 bullish TA indicator(s).

  • HALO’s TA Score: 5 bullish, 5 bearish.
  • IMCR’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, HALO is a better buy in the short-term than IMCR.

Price Growth

HALO (@Biotechnology) experienced а +2.62% price change this week, while IMCR (@Biotechnology) price change was -8.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.71%. For the same industry, the average monthly price growth was +15.03%, and the average quarterly price growth was +41.55%.

Reported Earning Dates

HALO is expected to report earnings on Nov 10, 2025.

IMCR is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.28B) has a higher market cap than IMCR($1.7B). HALO YTD gains are higher at: 23.510 vs. IMCR (14.746). HALO has higher annual earnings (EBITDA): 705M vs. IMCR (-97K). IMCR has more cash in the bank: 837M vs. HALO (748M). IMCR has less debt than HALO: IMCR (434M) vs HALO (1.51B). HALO has higher revenues than IMCR: HALO (1.08B) vs IMCR (334M).
HALOIMCRHALO / IMCR
Capitalization7.28B1.7B428%
EBITDA705M-97K-726,804%
Gain YTD23.51014.746159%
P/E Ratio15.70N/A-
Revenue1.08B334M325%
Total Cash748M837M89%
Total Debt1.51B434M347%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALOIMCR
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYIAX138.75N/A
N/A
Rydex Internet H
VRTPX21.70N/A
N/A
Vanguard Real Estate II Index
GILAX13.66N/A
N/A
Lord Abbett Fundamental Equity C
LGCSX19.21N/A
N/A
Lord Abbett Global Equity R4
BGAKX18.31N/A
N/A
Baillie Gifford Global Alpha Equities K

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with IDYA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
-0.27%
IDYA - IMCR
48%
Loosely correlated
-0.72%
XENE - IMCR
48%
Loosely correlated
-0.29%
NRIX - IMCR
48%
Loosely correlated
-0.17%
CRNX - IMCR
47%
Loosely correlated
-3.50%
EYPT - IMCR
46%
Loosely correlated
-1.79%
More